PMDA drug package insert
デプロニューターレス液0.2%
PMDA Prescription drug · 株式会社アルボース · package insert Apr 1, 2024
Key facts
| Brand names | デプロニューターレス液0.2% |
|---|---|
| Nonproprietary names | ベンゼトニウム塩化物 |
| Companies | 製造販売元／株式会社アルボース, 販売元／ササキ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 歯科用小器具消毒剤 |
| Therapeutic category codes | 877324 |
| YJ codes | 732480BQ1056 |
| Approval numbers | 21800AMX10264000 |
| Package insert edition | 第 1 版 |
| Package insert date | Apr 1, 2024 |
| PMDA document key | 100211_732480BQ1056_1 |
| PMDA company code | 100211 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: